Dr. Phil Ponce reflects on the progression of COVID treatments one year in, and discusses the biggest advances in the treatment for COVID-19 over the past year.  Lessons learned from the ACT2 trial study are discussed as well as lessons learned from other trials.  Preliminary studies on monulpiravir, and oral antiviral drug, is also discussed.